EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Curcumin and Cancer Stem Cells: Epigenetic Mechanisms Underlying Therapeutic Resistance and Tumor Relapse

Juie Nahushkumar Rana, Jayashri Ghosh, Sohail Mumtaz iD

International Journal of Molecular Sciences · 02.08.2026 · 27 (15) · 6945

DOI: 10.3390/ijms27156945 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2026. Verfasst von Juie Nahushkumar Rana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Hauptthemen laut MEDLINE: Curcumin, Neoplastic Stem Cells, Epigenesis, Genetic, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) drive therapeutic resistance, metastasis, and tumor recurrence through reversible transitions among stem-like, differentiated, epithelial, and mesenchymal states, which are sustained by interconnected epigenetic mechanisms. To our knowledge, this is the first review to integrate curcumin-mediated regulation of DNA methylation, chromatin remodeling, and non-coding RNAs within a single CSC plasticity framework and to propose the concept of an “epigenetic collapse of CSC plasticity” as a mechanistic explanation for how curcumin may weaken stemness, state switching, and adaptive treatment resistance. Evidence was critically evaluated through structured searches of PubMed/MEDLINE, Scopus, Web of Science Core Collection, Google Scholar, and citation tracking, while direct curcumin–epigenetic evidence was distinguished from independent CSC evidence and inferential mechanistic links. Curcumin has been reported to modulate DNMT1 and locus-specific DNA methylation; regulate HDACs, p300/CBP, EZH2, H3K27me3, and BMI1; and alter selected microRNA, long non-coding RNA, and circular RNA pathways, with comparatively stronger evidence involving the miR-34 family, miR-200c, miR-21, H19, and circHN1. However, current evidence is constrained by the predominance of bulk cancer-cell models, heterogeneous formulations and exposure conditions, and the scarcity of epigenetic rescue experiments combined with rigorous functional CSC assays. By unifying previously fragmented epigenetic evidence, this review advances a new evidence-weighted model in which curcumin may suppress CSC persistence not through a single molecular target, but by destabilizing the multilayer epigenetic circuitry that enables plasticity. Curcumin should therefore be regarded as a context-dependent, multilayer epigenetic modulator rather than an established CSC-eradicating therapy, and its translational relevance requires validation in prospectively defined CSC models with pharmacologically justified delivery and exposure conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminNeoplastic Stem CellsEpigenesis, GeneticDrug Resistance, NeoplasmNeoplasmsAntineoplastic AgentsNeoplasm Recurrence, LocalHumansDNA MethylationAnimalsGene Expression Regulation, NeoplasticMicroRNAs

Stichwörter der Autor:innen

DNA methylationcancer stem cellscurcuminepigenetic plasticityhistone remodelingnon-coding RNAtherapeutic resistancetumor relapse

Substanzen

CurcuminAntineoplastic AgentsMicroRNAs

Autor:innen und Institutionen

  • Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
  • Department of Chemical and Biological Engineering, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.

ORCID-Profile: Sohail Mumtaz

Zitieren

APA

Rana, J. N., Ghosh, J., & Mumtaz, S. (2026). Curcumin and Cancer Stem Cells: Epigenetic Mechanisms Underlying Therapeutic Resistance and Tumor Relapse. International Journal of Molecular Sciences, 27(15), 6945. https://doi.org/10.3390/ijms27156945

Vancouver

Rana JN, Ghosh J, Mumtaz S. Curcumin and Cancer Stem Cells: Epigenetic Mechanisms Underlying Therapeutic Resistance and Tumor Relapse. International Journal of Molecular Sciences. 2026;27(15):6945. doi:10.3390/ijms27156945

BibTeX
@article{Rana2026,
  author = {Rana, Juie Nahushkumar and Ghosh, Jayashri and Mumtaz, Sohail},
  title = {Curcumin and Cancer Stem Cells: Epigenetic Mechanisms Underlying Therapeutic Resistance and Tumor Relapse},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6945},
  doi = {10.3390/ijms27156945}
}
Kostenlos starten →